PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.75%
Negative revenue growth while ADI stands at 6.90%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.29%
Negative gross profit growth while ADI is at 7.50%. Joel Greenblatt would examine cost competitiveness or demand decline.
-0.24%
Negative EBIT growth while ADI is at 13.77%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
0.24%
Operating income growth under 50% of ADI's 13.77%. Michael Burry would be concerned about deeper cost or sales issues.
9.66%
Net income growth at 75-90% of ADI's 12.78%. Bill Ackman would press for improvements to catch or surpass competitor performance.
11.27%
EPS growth similar to ADI's 11.94%. Walter Schloss would assume both have parallel share structures and profit trends.
8.45%
Diluted EPS growth at 50-75% of ADI's 12.31%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-1.01%
Share reduction while ADI is at 0.40%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.59%
Reduced diluted shares while ADI is at 0.88%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
8.09%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
-6.68%
Negative OCF growth while ADI is at 22.01%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
0.76%
FCF growth under 50% of ADI's 27.38%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
72.41%
10Y revenue/share CAGR above 1.5x ADI's 14.06%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
34.31%
5Y revenue/share CAGR at 50-75% of ADI's 51.45%. Martin Whitman would worry about a lagging mid-term growth trajectory.
16.04%
3Y revenue/share CAGR under 50% of ADI's 52.42%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
177.75%
10Y OCF/share CAGR above 1.5x ADI's 21.70%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
85.39%
5Y OCF/share CAGR 1.25-1.5x ADI's 67.54%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
1.19%
3Y OCF/share CAGR under 50% of ADI's 49.96%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
120.11%
Net income/share CAGR above 1.5x ADI's 34.33% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
96.83%
Below 50% of ADI's 302.85%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
46.06%
Below 50% of ADI's 129.79%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
22.64%
Below 50% of ADI's 65.75%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
19.66%
5Y equity/share CAGR above 1.5x ADI's 6.06%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
22.49%
3Y equity/share CAGR at 50-75% of ADI's 36.81%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
511.63%
Dividend/share CAGR of 511.63% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
336.24%
5Y dividend/share CAGR above 1.5x ADI's 116.16%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
29.79%
3Y dividend/share CAGR above 1.5x ADI's 18.28%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-13.45%
Firm’s AR is declining while ADI shows 8.45%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.74%
Inventory growth well above ADI's 4.71%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.95%
Similar asset growth to ADI's 5.48%. Walter Schloss finds parallel expansions or investment rates.
5.84%
1.25-1.5x ADI's 5.04%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
-6.00%
Our R&D shrinks while ADI invests at 0.91%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-0.26%
We cut SG&A while ADI invests at 0.27%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.